At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
VOLBELLA® with lidocainedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Open Label Study Evaluating JUVÉDERM® VOLBELLA With Lidocaine Treatment for the Correction of Skin Depressions in the Infra-orbital Area
In Brief
A clinical study evaluating VOLBELLA® with lidocaine for Infra-orbital Skin Depressions. Completed, enrolled 80 participants across 1 site.
Detailed Summary
A prospective, open label, study evaluating JUVÉDERM® VOLBELLA with lidocaine treatment for the correction of skin depressions in the infra-orbital area (under the eyes)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfra-orbital Skin Depressions
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartMay 2014
First PostedJun 2014
Primary CompletionAug 2014
Study CompletionJul 2015
TodayJul 2026
First PostedJun 27, 2014
Enrollment StartMay 15, 2014
Primary CompletionAug 18, 2014
Study CompletionJul 3, 2015
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 12.0 years ago
Interventions
VOLBELLA® with lidocainedevice
VOLBELLA® with lidocaine administered to correct skin depression during initial treatment and optional top-up treatment 14 days later.